Clinical Research and Trials for Celiac Disease Patients
Learn about clinical trials to develop new treatments for celiac disease happening in Canada. You can play an important role in advancing research by participating in a clinical trial or study.
This page includes information on trials and studies in the celiac disease field. If you are interested in registering for a trial, use these links to find out if there one right for you.
For a complete listing of Clinical Trials available in Canada, please visit the Government of Canada’s Clinical Trials Database and search “celiac”. https://health-products.canada.ca/ctdb-bdec/?lang=eng
ASPIRION Study
The ASPIRION study is looking into a new, investigational study drug (amlitelimab) for patients with celiac disease. The aim of the study is to see whether the investigational study drug, in combination with a gluten-free diet, can reduce the damage in the small intestine and what effect it has on the symptoms caused by celiac disease.
You may be eligible to participate if you:
- Are 18 years or older
- Have a biopsy-proven diagnosis of celiac disease
- Have been on a gluten-free diet for at least 12 months but are still experiencing symptoms